Ads
related to: Merck COVID-19 Pill
Search results
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19...
Merck's COVID pill fails to prevent infection among household members
Reuters via Yahoo News· 1 year agoThe results were similar to data from rival Pfizer Inc, whose COVID pill Paxlovid also failed to...
EXPLAINER: COVID-19 pills must be taken within 5 days
Associated Press via Yahoo News· 2 years agoNewly infected COVID-19 patients have two treatment options that can be taken at home. The challenge...
Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows
Benzinga via Yahoo Finance· 1 year agoAccording to some researchers, Merck & Co’s (NYSE: MRK) COVID-pill is giving rise to new mutations...
UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced data from two real-world evidence...
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Committee for Medicinal...
Merck's COVID-19 Treatment Fails To Prevent Infection In Household Exposure
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) Lagevrio (molnupiravir) did not demonstrate a statistically significant...
Merck quarterly profit tops expectations on COVID pill surprise
Reuters via Yahoo Finance· 6 months ago(Reuters) -Merck & Co on Thursday reported higher-than-expected third-quarter results on...
European committee: Regulators should deny Merck's Lagevrio
AP Finance via Yahoo Finance· 1 year agoA European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting...
Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal...
